NHI Files 8-K for Other Events
Ticker: NHI · Form: 8-K · Filed: Sep 8, 2025 · CIK: 877860
| Field | Detail |
|---|---|
| Company | National Health Investors INC (NHI) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-events
TL;DR
NHI filed an 8-K for 'Other Events' - details TBD.
AI Summary
National Health Investors, Inc. (NHI) filed an 8-K on September 8, 2025, to report "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.
Why It Matters
This filing indicates that National Health Investors, Inc. has reported significant events that may impact its business operations or financial standing, requiring disclosure to investors.
Risk Assessment
Risk Level: medium — The filing is for 'Other Events' without specific details, creating uncertainty about potential impacts on the company.
Key Players & Entities
- National Health Investors, Inc. (company) — Registrant
- September 8, 2025 (date) — Date of Report
FAQ
What specific 'Other Events' are being reported by National Health Investors, Inc. in this 8-K filing?
The provided filing excerpt does not specify the nature of the 'Other Events' beyond the general categorization.
Does this 8-K filing disclose any financial transactions or agreements?
The excerpt does not contain information about specific financial transactions or agreements; it only indicates the filing of an 8-K for 'Other Events'.
Are there any new material contracts or amendments mentioned in this filing?
The filing is categorized under 'Other Events' and does not explicitly mention new material contracts or amendments in the provided text.
What is the significance of the filing date being September 8, 2025?
The filing date of September 8, 2025, signifies when National Health Investors, Inc. officially submitted this Current Report (8-K) to the SEC.
Does the filing provide any updates on the company's legal proceedings or regulatory matters?
The provided text does not offer any details regarding legal proceedings or regulatory matters; it is a general 'Other Events' filing.
Filing Stats: 558 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-09-08 16:07:39
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value NHI New York Stock Exchange
Filing Documents
- nhi-20250908.htm (8-K) — 22KB
- 0000877860-25-000162.txt ( ) — 136KB
- nhi-20250908.xsd (EX-101.SCH) — 2KB
- nhi-20250908_lab.xml (EX-101.LAB) — 22KB
- nhi-20250908_pre.xml (EX-101.PRE) — 13KB
- nhi-20250908_htm.xml (XML) — 3KB
From the Filing
nhi-20250908 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): September 8, 2025 National Health Investors, Inc. (Exact name of registrant as specified in its charter) Maryland 001-10822 62-1470956 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 222 Robert Rose Drive , Murfreesboro , TN 37129 (Address of principal executive offices) ( 615 ) 890-9100 (Registrant's telephone number, including area code) Not Applicable (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) Securities registered pursuant to Section 12(b) of the Act: Title of each Class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value NHI New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. I tem 8.01. Other Events. On July 29, 2025, National Health Investors, Inc. (NYSE: NHI) notified NHC/OP, L.P. ("Tenant"), an affiliate of National HealthCare Corporation ("NHC") and the tenant of thirty-two (32) of NHI's skilled nursing facilities and three (3) of NHI's independent living facilities, that Tenant was in non-compliance with several non-monetary provisions of the Master Agreement to Lease, dated October 17, 1991, as amended (the "Master Lease"), between NHI and Tenant. NHI's notification gave Tenant until August 29, 2025, to cure the specified areas of non-compliance. On September 8, 2025, NHI provided formal written notice to Tenant that it is in default under the Master Lease as a result of Tenant's failure to remedy its non-compliance with certain non-monetary provisions of the Master Lease identified by NHI. Pursuant to Section 9.01(c) of the Master Lease, if Tenant fails to cure such default within the thirty (30) day cure period (subject to certain limited exceptions) prescribed in the Master Lease, NHI may declare that an "Event of Default" (as defined in Section 9.01 of the Master Lease) by Tenant has occurred and thereafter NHI will be entitled to pursue any and all remedies available to NHI under the Master Lease. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. NATIONAL HEALTH INVESTORS, INC. By: /s/ John L. Spaid Name: John L. Spaid Title: Principal Financial Officer Date: September 8, 2025